Page last updated: 2024-10-16

carbamates and Triple Negative Breast Neoplasms

carbamates has been researched along with Triple Negative Breast Neoplasms in 3 studies

Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

Research Excerpts

ExcerptRelevanceReference
"These included acute lymphoblastic leukemia (ALL) and human breast cancer (BC) derived from two different tumor subtypes, ER+ invasive ductal carcinoma grade III (IDCG3) and metastatic carcinoma (MC)."1.56Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells-in vitro and ex vivo study. ( Chambers, TC; Huczyński, A; Jousheghany, F; Klejborowska, G; Majcher-Uchańska, U; Monzavi-Karbassi, B; Moorjani, A; Piña-Oviedo, S; Urbaniak, A; Yuan, Y, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Urbaniak, A1
Jousheghany, F1
Piña-Oviedo, S1
Yuan, Y1
Majcher-Uchańska, U1
Klejborowska, G1
Moorjani, A1
Monzavi-Karbassi, B1
Huczyński, A1
Chambers, TC1
Guo, B1
Rodriguez-Gabin, A1
Prota, AE1
Mühlethaler, T1
Zhang, N1
Ye, K1
Steinmetz, MO1
Horwitz, SB1
Smith, AB1
McDaid, HM1
Alothaim, T1
Charbonneau, M1
Tang, X1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Single-center Clinical Trial to Evaluate the Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients[NCT05802992]Phase 330 participants (Anticipated)Interventional2022-03-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for carbamates and Triple Negative Breast Neoplasms

ArticleYear
Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells-in vitro and ex vivo study.
    Journal of biochemical and molecular toxicology, 2020, Volume: 34, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carbamates; Carcinoma, Ductal, Breast; Cell Proliferat

2020
Structural Refinement of the Tubulin Ligand (+)-Discodermolide to Attenuate Chemotherapy-Mediated Senescence.
    Molecular pharmacology, 2020, Volume: 98, Issue:2

    Topics: A549 Cells; Alkanes; Area Under Curve; Carbamates; Cell Line, Tumor; Cell Survival; Crystallography,

2020
HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation.
    Scientific reports, 2021, 05-26, Volume: 11, Issue:1

    Topics: Anilides; Carbamates; Cell Death; Cell Line, Tumor; Cysteine; Enzyme Activation; Epithelial Cells; F

2021